Henry Schein (HSIC) came out with quarterly earnings of $1.23 per share, beating the Zacks Consensus Estimate of $1.22 per share. This compares to earnings of $1.31 per share a year ago.
Henry Schein lowered its annual profit forecast on Tuesday as the dental and medical equipment distributor warned of a slower recovery from a cyberattack that was disclosed by the company in October last year.
Evaluate the expected performance of Henry Schein (HSIC) for the quarter ended June 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Henry Schein (HSIC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Henry Schein (HSIC) is expected to deliver impressive sales in both its businesses in the second quarter of 2024, along with a steady pace of recovery from the cyber incident.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Henry Schein (HSIC) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Robust acquisitions and a widespread distribution network bode well for Henry Schein's (HSIC) operations.
Henry Schein's (HSIC) revenue growth is supported by niche acquisitions and partnerships.
It's been an interesting year for the stock market. The major indices keep plowing to new all-time highs.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.